201 related articles for article (PubMed ID: 1334552)
1. Differential stereochemical requirements of mu vs. delta opioid receptors for ligand binding and signal transduction: development of a class of potent and highly delta-selective peptide antagonists.
Schiller PW; Nguyen TM; Weltrowska G; Wilkes BC; Marsden BJ; Lemieux C; Chung NN
Proc Natl Acad Sci U S A; 1992 Dec; 89(24):11871-5. PubMed ID: 1334552
[TBL] [Abstract][Full Text] [Related]
2. Conformationally restricted deltorphin analogues.
Schiller PW; Weltrowska G; Nguyen TM; Wilkes BC; Chung NN; Lemieux C
J Med Chem; 1992 Oct; 35(21):3956-61. PubMed ID: 1331451
[TBL] [Abstract][Full Text] [Related]
3. Conformational restriction of the phenylalanine residue in a cyclic opioid peptide analogue: effects on receptor selectivity and stereospecificity.
Schiller PW; Weltrowska G; Nguyen TM; Lemieux C; Chung NN; Marsden BJ; Wilkes BC
J Med Chem; 1991 Oct; 34(10):3125-32. PubMed ID: 1656045
[TBL] [Abstract][Full Text] [Related]
4. Opioid activity of dermenkephalin analogues in the guinea-pig myenteric plexus and the hamster vas deferens.
Sagan S; Corbett AD; Amiche M; Delfour A; Nicolas P; Kosterlitz HW
Br J Pharmacol; 1991 Oct; 104(2):428-32. PubMed ID: 1665735
[TBL] [Abstract][Full Text] [Related]
5. Design and synthesis of somatostatin analogues with topographical properties that lead to highly potent and specific mu opioid receptor antagonists with greatly reduced binding at somatostatin receptors.
Kazmierski W; Wire WS; Lui GK; Knapp RJ; Shook JE; Burks TF; Yamamura HI; Hruby VJ
J Med Chem; 1988 Nov; 31(11):2170-7. PubMed ID: 2903246
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and activity profiles of novel cyclic opioid peptide monomers and dimers.
Schiller PW; Nguyen TM; Lemieux C; Maziak LA
J Med Chem; 1985 Dec; 28(12):1766-71. PubMed ID: 2999401
[TBL] [Abstract][Full Text] [Related]
7. Dermenkephalin (Tyr-D-Met-Phe-His-Leu-Met-Asp-NH2): a potent and fully specific agonist for the delta opioid receptor.
Amiche M; Sagan S; Mor A; Delfour A; Nicolas P
Mol Pharmacol; 1989 Jun; 35(6):774-9. PubMed ID: 2543911
[TBL] [Abstract][Full Text] [Related]
8. Novel peptidic mu opioid antagonists: pharmacologic characterization in vitro and in vivo.
Kramer TH; Shook JE; Kazmierski W; Ayres EA; Wire WS; Hruby VJ; Burks TF
J Pharmacol Exp Ther; 1989 May; 249(2):544-51. PubMed ID: 2566679
[TBL] [Abstract][Full Text] [Related]
9. Synthesis of highly mu and delta opioid receptor selective peptides containing a photoaffinity group.
Landis G; Lui G; Shook JE; Yamamura HI; Burks TF; Hruby VJ
J Med Chem; 1989 Mar; 32(3):638-43. PubMed ID: 2537426
[TBL] [Abstract][Full Text] [Related]
10. Dermenkephalin and deltorphin I reveal similarities within ligand-binding domains of mu- and delta-opioid receptors and an additional address subsite on the delta-receptor.
Charpentier S; Sagan S; Delfour A; Nicolas P
Biochem Biophys Res Commun; 1991 Sep; 179(3):1161-8. PubMed ID: 1656944
[TBL] [Abstract][Full Text] [Related]
11. Molecular determinants of receptor affinity and selectivity of the natural delta-opioid agonist, dermenkephalin.
Sagan S; Amiche M; Delfour A; Mor A; Camus A; Nicolas P
J Biol Chem; 1989 Oct; 264(29):17100-6. PubMed ID: 2551895
[TBL] [Abstract][Full Text] [Related]
12. Opioid receptor selectivity of beta-endorphin in vitro and in vivo: mu, delta and epsilon receptors.
Shook JE; Kazmierski W; Wire WS; Lemcke PK; Hruby VJ; Burks TF
J Pharmacol Exp Ther; 1988 Sep; 246(3):1018-25. PubMed ID: 2843623
[TBL] [Abstract][Full Text] [Related]
13. Development of conformationally constrained linear peptides exhibiting a high affinity and pronounced selectivity for delta opioid receptors.
Gacel G; Daugé V; Breuzé P; Delay-Goyet P; Roques BP
J Med Chem; 1988 Oct; 31(10):1891-7. PubMed ID: 2845081
[TBL] [Abstract][Full Text] [Related]
14. Characterisation and visualisation of [3H]dermorphin binding to mu opioid receptors in the rat brain. Combined high selectivity and affinity in a natural peptide agonist for the morphine (mu) receptor.
Amiche M; Sagan S; Mor A; Pelaprat D; Rostene W; Delfour A; Nicolas P
Eur J Biochem; 1990 May; 189(3):625-35. PubMed ID: 2161761
[TBL] [Abstract][Full Text] [Related]
15. Opioid agonist activity of ICI 174864 and its carboxypeptidase degradation product, LY281217.
Cohen ML; Shuman RT; Osborne JJ; Gesellchen PD
J Pharmacol Exp Ther; 1986 Sep; 238(3):769-72. PubMed ID: 2875170
[TBL] [Abstract][Full Text] [Related]
16. Ring substituted and other conformationally constrained tyrosine analogues of [D-Pen2,D-Pen5]enkephalin with delta opioid receptor selectivity.
Toth G; Russell KC; Landis G; Kramer TH; Fang L; Knapp R; Davis P; Burks TF; Yamamura HI; Hruby VJ
J Med Chem; 1992 Jun; 35(13):2384-91. PubMed ID: 1320122
[TBL] [Abstract][Full Text] [Related]
17. Modification of the Phe3 aromatic moiety in delta receptor-selective dermorphin/deltorphin-related tetrapeptides. Effects on opioid receptor binding.
Heyl DL; Mosberg HI
Int J Pept Protein Res; 1992 May; 39(5):450-7. PubMed ID: 1330964
[TBL] [Abstract][Full Text] [Related]
18. A novel cyclic opioid peptide analog showing high preference for mu-receptors.
Schiller PW; Nguyen TM; Maziak L; Lemieux C
Biochem Biophys Res Commun; 1985 Mar; 127(2):558-64. PubMed ID: 2983726
[TBL] [Abstract][Full Text] [Related]
19. Structure-activity relationships of the delta-opioid-selective agonists, deltorphins.
Melchiorri P; Negri L; Falconieri-Erspamer G; Severini C; Corsi R; Soaje M; Erspamer V; Barra D
Eur J Pharmacol; 1991 Mar; 195(2):201-7. PubMed ID: 1651862
[TBL] [Abstract][Full Text] [Related]
20. Cyclic, disulfide- and dithioether-containing opioid tetrapeptides: development of a ligand with high delta opioid receptor selectivity and affinity.
Mosberg HI; Omnaas JR; Medzihradsky F; Smith CB
Life Sci; 1988; 43(12):1013-20. PubMed ID: 2845204
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
